A leading Ukrainian pharmaceutical manufacturer has been acquired by a Spaniard, Vicente Moros. After three years of negotiations with the Ukrainian authorities, Mr Moros has been given the go-ahead for the deal. From May, he will produce three antibiotic products, anti-inflammatories and vitamins for the Ukrainian market, and may soon begin exporting to neighboring states.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze